Clopidogrel, a CYP2C8 inhibitor, causes a clinically relevant increase in the systemic exposure to the active metabolite of selexipag in healthy subjects
Author:
Affiliation:
1. Department of Clinical Pharmacology Actelion Pharmaceuticals Ltd Allschwil Switzerland
2. Clinical Pharmacology Unit Janssen Pharmaceutica NV Merksem Belgium
Funder
Actelion Pharmaceuticals
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14365
Reference36 articles.
1. Pulmonary Arterial Hypertension
2. The prostacyclin pathway in pulmonary arterial hypertension: a clinical review
3. Pathology of Pulmonary Hypertension
4. Prostanoid therapy for pulmonary arterial hypertension
5. Prostacyclin Therapy for Pulmonary Arterial Hypertension: New Directions
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension;Chest;2022-12
2. Drug Interactions Associated With Therapies for Pulmonary Arterial Hypertension;Journal of Pharmacy Technology;2022-08-08
3. Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions;Pharmaceutics;2022-04-22
4. Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles;Pharmaceutical Biology;2021-12-03
5. Translational aspects of cytochrome P450‐mediated drug–drug interactions: A case study with clopidogrel;Basic & Clinical Pharmacology & Toxicology;2021-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3